Table 2.
Revascularization and drug therapy during follow-up
Therapy, n (%) | Patients with MI without type 2 diabetes (n = 95) | Patients with MI and type 2 diabetes (n = 60) |
---|---|---|
β-blockers | 85 (89.5) | 51 (85) |
Angiotensin-converting enzyme | 78 (82.1) | 51 (85) |
Calcium channel blocker | 66 (69.5) | 39 (65) |
Diuretics | 40 (42) | 39 (60) |
Nitrates | 83 (87.4) | 31 (51.6) |
Aspirin | 94 (87.8) | 55 (91.6) |
Heparin | 95 (100) | 60 (100) |
Clopidogrel | 84 (78.5) | 44 (73.3) |
Statins | 95 (100) | 60 (100) |
Abbreviation: MI, myocardial infarction.